Recent Security Class Actions

According to the Complaint, Decision Diagnostics Corp. purportedly offers, among other products and services, prescription and non-prescription diagnostics and home testing products. From March 2020 to at least June 2020, Defendants claimed that the Company had developed a finger-prick blood test that could detect COVID-19 in less than one minute. Defendants also made various representations regarding the Company’s progress towards achieving U.S. Food and Drug Administration emergency use authorization (“EUA”) for this purported COVID-19 finger-prick blood test.